The fourth quarter sell-off hurt big medtech less than big pharma
Some medtech stocks did decline in 2018, but many more increased in value.
Medtechs prioritise efficiency when it comes to hiring
Big cap medtech is hiring, largely thanks to organic growth.
Smaller medtechs soar in ’17 but could now be too expensive
Many small groups are up thanks to takeover speculation, and this may end up being self-defeating.
2017 saw the stars Align for big-cap medtech
Toothy grins all round at Align, but it is unclear how much longer it can keep up its scorching rate of sales growth.
Lack of takeovers sees medtech hiring staff again
Intuitive Surgical is the winner in terms of sales per employee, despite increasing its headcount 17%.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.